HWM
TNDM icon

HighMark Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

HighMark Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515K Hold
34,120
– – 0.17% 52
2026
Q1 		$654K Sell
34,120
-1,000
-3% -$21.7K 0.27% 45
2025
Q4 		$772K Buy
35,120
+11,550
+49% +$208K 0.31% 42
2025
Q3 		$286K Sell
23,570
-100
-0.4% -$1.35K 0.13% 65
2025
Q2 		$441K Sell
23,670
-1,500
-6% -$29.7K 0.22% 54
2025
Q1 		$482K Hold
25,170
– – 0.28% 35
2024
Q4 		$907K Sell
25,170
-2,000
-7% -$67.7K 0.52% 24
2024
Q3 		$1.15M Hold
27,170
– – 0.63% 23
2024
Q2 		$1.09M Hold
27,170
– – 0.66% 20
2024
Q1 		$962K Hold
27,170
– – 0.6% 19
2023
Q4 		$804K Hold
27,170
– – 0.59% 20
2023
Q3 		$564K Buy
27,170
+2,870
+12% +$78.8K 0.47% 22
2023
Q2 		$596K Buy
24,300
+925
+4% +$29.8K 0.45% 26
2023
Q1 		$949K Hold
23,375
– – 0.74% 21
2022
Q4 		$1.05M Hold
23,375
– – 0.79% 20
2022
Q3 		$1.12M Hold
23,375
– – 0.95% 14
2022
Q2 		$1.38M Hold
23,375
– – 1.11% 12
2022
Q1 		$2.72M Hold
23,375
– – 1.82% 8
2021
Q4 		$3.52M Sell
23,375
-243
-1% -$32.8K 2.23% 9
2021
Q3 		$2.82M Buy
23,618
+15
+0.1% +$1.65K 2.08% 9
2021
Q2 		$2.3M Buy
23,603
+34
+0.1% +$3.03K 1.69% 12
2021
Q1 		$2.08M Sell
23,569
-767
-3% -$71.3K 1.66% 10
2020
Q4 		$2.33M Buy
24,336
+9
+0% +$928 2% 9
2020
Q3 		$2.76M Buy
24,327
+851
+4% +$89.4K 2.49% 10
2020
Q2 		$2.32M Buy
23,476
+101
+0.4% +$8.06K 2.55% 8
2020
Q1 		$1.5M Hold
23,375
– – 1.82% 8
2019
Q4 		$1.39M Buy
+23,375
New +$1.44M 1.49% 7

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

HighMark Wealth Management's TNDM Position: Q2 2026 in Review

HighMark Wealth Management held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 34,120 shares worth $515K. The position accounts for 0.17% of the portfolio, ranked #52.

HighMark Wealth Management first reported a position in TNDM in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.52M in Q4 2021. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • HighMark Wealth Management held 34,120 shares of Tandem Diabetes Care worth $515K as of Q2 2026.
  • HighMark Wealth Management left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up 0.17% of HighMark Wealth Management's portfolio in Q2 2026, its #52 holding.
  • HighMark Wealth Management first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 27 quarters since.
  • HighMark Wealth Management's Tandem Diabetes Care position peaked at $3.52M in Q4 2021.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.